Dispensing Pharmacy Bankruptcy Trends (FY2025): “Monzen” Pharmacies Near Hospitals Face Hardship; Bankruptcies to Hit 30 in FY2025, a Record High for Two Consecutive Years – au Web Portal

News Highlights

The number of dispensing pharmacy bankruptcies is expected to reach 30 in FY2025, marking a record high for the second consecutive year. “Monzen” pharmacies, located near hospitals, are particularly struggling, highlighting changes in regional healthcare systems and the increasing difficulties in pharmacy management. This underscores the importance of business succession through early consultation with experts, negotiation for the release of personal guarantees, and M&A that considers regional healthcare needs.

M&A Medical Editorial Department’s Perspective

The fact that the number of dispensing pharmacy bankruptcies is projected to hit a record high for the second year in a row signifies more than just a numerical increase; it holds the potential to shake the foundations of regional healthcare. The struggles of “Monzen” pharmacies are likely due to a combination of structural issues, such as the expansion of large drugstores, a decrease in prescription volumes resulting from hospital reorganizations and consolidations, and the lack of successors. The projected 30 bankruptcies in FY2025 suggest that a considerable number of pharmacies are facing these challenges. Business succession through M&A while the business is still healthy can lead to benefits such as maintaining the patient base and staff employment, as well as releasing the owner’s personal guarantees. This situation is of concern not only to dispensing pharmacies but also to the healthcare institutions they collaborate with.

Key Discussion Points from This News

• The hardship faced by “Monzen” pharmacies indicates changes in regional healthcare systems and structural challenges in pharmacy management.
• The figure of 30 bankruptcies in FY2025 reflects the reality that many pharmacies are being forced to consider M&A and business succession.
• M&A conducted while the business is in good health is highly likely to lead to the release of personal guarantees and the maintenance of patient and staff employment.
• The increase in dispensing pharmacy bankruptcies is a problem that cannot be overlooked from the perspective of the continuity of regional healthcare.

Practical Questions Arising from This News

• What are the specific factors causing “Monzen” pharmacies to face hardship?
• Amidst increasing bankruptcies, what M&A schemes are considered effective?
• When should pharmacies with a lack of successors consider M&A at an early stage?

If You Feel “Should I Consult?”

The news that dispensing pharmacy bankruptcies are expected to reach a record high in FY2025 may prompt you to feel concerned about your own pharmacy’s management. Especially if you are worried about a lack of successors or declining profitability, consulting with experts early on can significantly broaden your options. For example, by considering M&A while the business is still healthy, the possibility of releasing the owner’s personal guarantees and the possibility of business succession by transferring patients and staff employment increase. Let’s start by accurately assessing the current situation and gathering information on the available options.

M&A Medical (CentralMedience Inc.) supports the business succession of medical corporations, hospitals, and clinics as a business succession support institution certified by the Small and Medium Enterprise Agency, with a full success fee basis. We handle consultations with strict confidentiality. Free consultation here.